{"id":17429,"date":"2023-01-19T11:06:02","date_gmt":"2023-01-19T09:06:02","guid":{"rendered":"https:\/\/atostek.com\/secondary-use-of-health-data\/"},"modified":"2025-05-20T12:40:55","modified_gmt":"2025-05-20T09:40:55","slug":"secondary-use-of-health-data","status":"publish","type":"page","link":"https:\/\/atostek.com\/en-us\/services\/secondary-use-of-health-data\/","title":{"rendered":"Secondary use of health data"},"content":{"rendered":"
[vc_row full_width=”stretch_row” parallax=”content-moving” parallax_image=”12779″ wpex_bg_overlay=”custom” css=”.vc_custom_1673346684255{padding-top: 10vh !important;padding-bottom: 5vh !important;background-color: #072d55 !important;}” wpex_bg_overlay_color=”#072d55″ wpex_bg_overlay_opacity=”0.85″][vc_column css=”.vc_custom_1479553360477{margin-bottom: 5px !important;}”][vc_column_text]\n

SERVICES<\/p>\n[\/vc_column_text][vc_column_text color=”#ffffff”]\n

Better Quality and Cost Savings Through Secondary Use of Health Data<\/b><\/h1>\n

Medicine produces valuable data that can be used to increase life expectancy and improve the quality of life. The Finnish Act on the Secondary Use of Health and Social Data permits the secondary use of Kanta information for research purposes.<\/b>[\/vc_column_text][vc_column_text]
\n\"\" Book a meeting with our expert<\/a><\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1673345661735{padding-top: 35px !important;padding-bottom: 35px !important;}”][vc_column width=”3\/4″][vc_column_text]\n

Multiple Possibilities of Secondary Use<\/h2>\n

Through secondary use, anonymized data from health and social services can be used for research purposes. When a large amount of data is manipulated by means of artificial intelligence or statistical methods, it is possible to develop tools for disease risk prediction and for screening, for example. Research in medicines and treatment methods also benefits from access to large masses of data.<\/span><\/p>\n[\/vc_column_text][\/vc_column][vc_column width=”1\/4″][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1673345735274{padding-top: 35px !important;padding-bottom: 35px !important;background-color: #84bd00 !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column][vc_column_text color=”#ffffff”]\n

Atostek, Leading Expert on Secondary Use of Kanta Data<\/h2>\n

Atostek has years of experience in managing data in the health and social services sector, and in the utilization of Kanta data. Our ERA service provides a versatile test environment in which you can generate test data in authentic format and which has all the tools necessary for efficient processes of Kanta data.<\/span><\/p>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” parallax=”content-moving” parallax_image=”12798″ css=”.vc_custom_1673340771459{padding-top: 35px !important;padding-bottom: 35px !important;background-color: #f4f4f4 !important;}”][vc_column width=”2\/3″][vc_column_text css=”.vc_custom_1736927899016{padding-right: 5vw !important;}”]\n

Secondary Use in Research Projects<\/h2>\n

Is your organization planning a research project involving secondary use of data?<\/span><\/p>\n

We know what must be considered in research projects involving secondary use of data. Our highly trained staff, some at doctorate level, will be able to meet any data science research problem. We are familiar with the legal provisions concerning secondary use of data and take data security and data protection very seriously.<\/span><\/p>\n

Atostek\u2019s innovative Jasmine research project has received permission from Findata, the Finnish Social and Health Data Permit Authority, to use Kanta material. The project focuses on the automatic utilization and refinement of health data by means of machine learning in particular. Artificial intelligence and risk calculators for various diseases have been applied to the mass of data in the project.<\/span>[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1673340400774{padding-top: 10vh !important;}”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1736927201343{padding-top: 20px !important;}”]\n

Research and Publications<\/h2>\n[\/vc_column_text]
<\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/3″]

Large-Scale Evaluation and Liver Disease Risk Prediction in Finland\u2019s National Electronic Health Record System: Feasibility Study Using Real-World Data \u2013 JMIR Medical Informatics<\/h2>

Authors: Viljami M\u00e4nnikk\u00f6, Janne Tommola, Emmi Tikkanen, Olli-Pekka H\u00e4tinen and\u00a0Fredrik \u00c5berg<\/em><\/span><\/p>\n

Globally, the incidence and mortality of chronic liver disease are escalating. Early detection of liver disease remains a challenge, often occurring at symptomatic stages when preventative measures are less effective. The Chronic Liver Disease score (CLivD) is a predictive risk model developed using Finnish health care data, aiming to forecast an individual\u2019s risk of developing chronic liver disease in subsequent years.<\/p>\n

The Kanta Service is a national electronic health record system in Finland that stores comprehensive health care data including patient medical histories, prescriptions, and laboratory results, to facilitate health care delivery and research…<\/p>\n<\/div>

Read more<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″]

A Large-Scale Risk Assessment and Classification Model for Pneumococcus Using Finnish National Health Data \u2013 Healthcare Analytics<\/h2>

Authors: Viljami M\u00e4nnikk\u00f6, Juha Turunen, Heidi \u00c5hman and Esa Harju<\/em><\/span><\/p>\n

Streptococcus pneumoniae<\/em>, or pneumococcus, poses a significant health risk, particularly to infants, the elderly, and individuals with underlying medical conditions. In Finland, pneumococcal vaccination is part of the national immunization program, with vaccination provided to young children and only selected at-risk adult populations included.<\/p>\n

This study aims to leverage the Finnish national electronic health record system, Kanta, to analyze treatment histories and identify individuals at increased risk for disease to improve vaccination strategies\u2026<\/p>\n<\/div>

Read more<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″]

Finnish National Patient Data Repository as Data Source for FINRISK Risk Calculator \u2013 Finnish Journal of eHealth and eWelfare<\/h2>

Authors: Viljami M\u00e4nnikk\u00f6, Henna Kujanen, Joona Munukka and Klaus F\u00f6rger<\/em><\/span><\/p>\n

The FINRISK risk calculator is a tool for the evaluation of the 10-year risk of cardiovascular diseases (CVDs). It is based on a Finnish population survey and is frequently used in Finnish healthcare. Currently, risks are calculated manually by inputting the required values.<\/p>\n

An alternative source of input values could be the Finnish Kanta Patient Data Repository (PDR). Risk calculation based on the Kanta PDR could enable monitoring of predicted CVD risks at the level of the Finnish population and targeting of preventive healthcare to high-risk individuals\u2026<\/p>\n<\/div>

Read more<\/a><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/3″]

Overview of Finnish National Patient Data Repository for Research on Medical Risk Assessment \u2013 Finnish Journal of eHealth and eWelfare<\/h2>

Authors: Viljami M\u00e4nnikk\u00f6, Klaus F\u00f6rger, Henna Urhonen, Jani Tikkanen, Simo Antikainen and Joona Munukka<\/em><\/span><\/p>\n

The Kanta Patient Data Repository contains healthcare data from the population of Finland for more than a decade. The repository is a continuously expanding real world dataset produced by many information systems and healthcare service providers.<\/p>\n

Kanta data has been accessible for secondary uses such as scientific research since 2019. The data can be requested from the Finnish authority Findata. However, before a request has been accepted, it is difficult to assess if the accumulated data allows answering a specific research question…<\/p>\n<\/div>

Read more<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″]

Compatibility of Medical Risk Calculators with Data from Finnish National Health Record System \u2013 Finnish Society of Telemedicine and eHealth<\/h2>

Authors: Viljami M\u00e4nnikk\u00f6, Klaus F\u00f6rger and Henna Urhonen<\/em><\/span><\/p>\n

Medical risk calculators are effective tools in preventative healthcare. Kanta Services is a Finnish national healthcare data registry that contains data from almost the whole Finnish population. This work presents an estimate if the input variables of medical risk calculators can be found from Kanta.<\/p>\n

With medical risk calculators, the development of an individual\u2019s health can be monitored by individuals themselves, by healthcare professionals, or as a result of selective mass analysis. This helps to detect high-risk potential for certain diseases at an early stage…<\/p>\n<\/div>

Read more<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1736927245300{background-color: #f4f4f4 !important;}”][vc_column][vc_column_text]\n

Read More<\/h2>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1736927280380{background-color: #f4f4f4 !important;}”][vc_column width=”1\/3″]
\"\"<\/div>

Cost savings through secondary use of health data<\/h2>

29.4.2025 |<\/strong> Finland is considered a pioneer in the secondary use of health data. Secondary use enables new innovative solutions to address challenges in healthcare. However, regulatory challenges remain an obstacle to implementing these new solutions.<\/p>\n<\/div>

READ MORE<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″]
\"\"<\/div>

Can the risk of disease be predicted? Pfizer\u2019s and Atostek\u2019s research studies the potential of Kanta data for the automated identification of disease risks<\/h2>

13.1.2025 |<\/strong> Pfizer and Atostek studied how Finland\u2019s Kanta data could be utilized to predict disease risks. The aim is to improve the early identification of chronic diseases and illnesses like pneumococcal disease.<\/p>\n<\/div>

READ MORE<\/a><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″]
\"\"<\/div>

Utilizing Kanta data in research \u2013 Consider these factors during the planning phase<\/h2>

5.9.2024 |<\/strong> When planning to utilize Kanta data for research purposes, it is advisable to pay close attention to accurately defining your data needs from the very beginning.<\/p>\n<\/div>

READ MORE<\/a><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row css=”.vc_custom_1673339518199{padding-top: 2vh !important;}”][vc_column width=”1\/2″][vc_column_text]\n

Let’s Talk<\/h2>\n

\"\"<\/p>\n

Juho Lepp\u00e4m\u00e4ki<\/h3>\n

Secondary Use of Health Data & Medical Devices
\njuho.leppamaki@atostek.com<\/a>
\n+358 45 113 8883<\/p>\n

\"\"Book a meeting<\/a><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n[\/vc_column_text][\/vc_column][vc_column width=”1\/2″][vc_column_text]\n

Contact Us<\/h2>\n

You can also leave us a message via the form below. We will contact you as soon as possible.[\/vc_column_text][vc_raw_html]JTNDc2NyaXB0JTIwY2hhcnNldCUzRCUyMnV0Zi04JTIyJTIwdHlwZSUzRCUyMnRleHQlMkZqYXZhc2NyaXB0JTIyJTIwc3JjJTNEJTIyJTJGJTJGanMtZXUxLmhzZm9ybXMubmV0JTJGZm9ybXMlMkZlbWJlZCUyRnYyLmpzJTIyJTNFJTNDJTJGc2NyaXB0JTNFJTBBJTNDc2NyaXB0JTNFJTBBJTIwJTIwaGJzcHQuZm9ybXMuY3JlYXRlJTI4JTdCJTBBJTIwJTIwJTIwJTIwcmVnaW9uJTNBJTIwJTIyZXUxJTIyJTJDJTBBJTIwJTIwJTIwJTIwcG9ydGFsSWQlM0ElMjAlMjIyNTUxNTcyMCUyMiUyQyUwQSUyMCUyMCUyMCUyMGZvcm1JZCUzQSUyMCUyMjU3MGRiOTYwLWRiYjQtNGM1ZC05ZTNkLWEzMmI5MDViYTY4MCUyMiUwQSUyMCUyMCU3RCUyOSUzQiUwQSUzQyUyRnNjcmlwdCUzRQ==[\/vc_raw_html][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch_row” parallax=”content-moving” parallax_image=”12779″ wpex_bg_overlay=”custom” css=”.vc_custom_1673346684255{padding-top: 10vh !important;padding-bottom: 5vh !important;background-color: #072d55 !important;}” wpex_bg_overlay_color=”#072d55″ wpex_bg_overlay_opacity=”0.85″][vc_column css=”.vc_custom_1479553360477{margin-bottom: 5px !important;}”][vc_column_text] SERVICES [\/vc_column_text][vc_column_text color=”#ffffff”] Better Quality and Cost Savings Through Secondary Use of Health Data Medicine produces valuable data that can be used to increase life expectancy and improve the quality of life. The Finnish Act on the Secondary…<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":17432,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-17429","page","type-page","status-publish","hentry","entry","no-media"],"_links":{"self":[{"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/pages\/17429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/comments?post=17429"}],"version-history":[{"count":12,"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/pages\/17429\/revisions"}],"predecessor-version":[{"id":18435,"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/pages\/17429\/revisions\/18435"}],"up":[{"embeddable":true,"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/pages\/17432"}],"wp:attachment":[{"href":"https:\/\/atostek.com\/en-us\/wp-json\/wp\/v2\/media?parent=17429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}